GE HealthCare (Nasdaq: GEHC) today unveiled SIGNA™ Sprint, an FDA 510(k) pending1 ultra-premium wide bore 1.5T high-performance gradient MRI system, at the International Society for Magnetic Resonance in Medicine (ISMRM) 2025. This innovative technology is designed to unlock advanced imaging possibilities in cardiology, oncology and other clinical and research areas..

GE医疗（纳斯达克股票代码：GEHC）今天在国际医学磁共振学会（ISMRM）2025上推出了SIGNA™ Sprint，这是一款正在等待FDA 510(k)审批的超高端宽孔1.5T高性能梯度磁共振成像系统。这项创新技术旨在解锁心脏病学、肿瘤学及其他临床和研究领域的先进成像可能性。

The need for advanced diagnostics in cardiology and oncology continues to grow, with cardiovascular disease accounting for 32% of global deaths,2 and cancer accounting for nearly 10 million deaths per year.3 Meeting this demand with advanced MRI technologies has the potential to make significant impact for cardiology and oncology patients..

心脏病学和肿瘤学对高级诊断的需求持续增长，心血管疾病占全球死亡人数的32%，而癌症每年导致近1000万人死亡。利用先进的MRI技术满足这一需求，有望为心脏病学和肿瘤学患者带来重大影响。

With the goal of delivering higher gradient benefits previously attainable on only 3.0T systems, SIGNA Sprint is designed to offer high-performance scanning made simple at 1.5T, with exceptional diffusion imaging, a critical tool in oncology diagnosis and treatment planning. SIGNA Sprint is also designed to equip clinicians and researchers with the ability to expand the current 1.5T boundaries, aiming to enable fast clinical translation and pioneering research..

为了实现以往仅在3.0T系统上才能获得的更高梯度性能，SIGNA Sprint旨在以1.5T提供高性能且简化的扫描，具备卓越的扩散成像能力，这是肿瘤诊断和治疗规划中的关键工具。SIGNA Sprint还旨在为临床医生和研究人员提供拓展当前1.5T边界的能力，力求推动快速临床转化和开创性研究。

SIGNA Sprint, with a high-gradient performance of 65/200 per axis for fast imaging and exceptional image quality, is designed to deliver crystal-clear visualization of sub-millimetric structures and deep learning solutions to support diagnostics and treatment response monitoring in oncology patients.

SIGNA Sprint 拥有每轴65/200的高梯度性能，可实现快速成像和卓越的图像质量，旨在提供亚毫米级结构的清晰可视化，并通过深度学习解决方案支持肿瘤学患者的诊断和治疗反应监测。

This new system supports clinicians’ shift to quantitative MRI and a deeper understanding of tissue characteristics, going beyond basic assessment of anatomy. The adoption of deep-learning reconstruction techniques for accelerated cardiac MRI aims to reduce the time and expertise needed to interpret scans and drive consistency and reliability..

该新系统支持临床医生转向定量MRI，并更深入地了解组织特性，而不仅仅是基本的解剖结构评估。采用深度学习重建技术进行加速的心脏MRI旨在减少解读扫描所需的时间和专业知识，并提高一致性和可靠性。

“We are driven to push the boundaries of what’s possible in MRI with our ultra-premium segment, as our goal is to set a new standard in diagnostic research and precision care that allows for earlier clinical detection and treatment response,” said Kelly Londy, CEO, MR, GE HealthCare. “We are working to enhance diagnostic capabilities to provide highly accurate imaging with peace of mind for patients.

“我们致力于通过超高端领域的MRI技术突破可能的界限，因为我们的目标是为诊断研究和精准护理树立新的标准，从而实现更早的临床检测和治疗反应，”GE医疗磁共振事业部首席执行官凯利·隆迪表示。“我们正在努力提升诊断能力，为患者提供高度精确的成像，并让他们安心。”

We hope to help clinicians unlock new horizons for research in advanced imaging.”.

我们希望能够帮助临床医生开拓先进影像研究的新视野。

SIGNA Sprint also is designed to optimize patient comfort, providing a 70cm wide bore space, free-breathing capabilities, and blanket-like AIR ™ Coils to improve the patient experience. This next-generation, high-performance platform is designed to benefit from built-in AI technologies – AIR™ Recon DL, Sonic DL™ and AIR x™ – which enable high-quality imaging even in the most demanding anatomies.

SIGNA Sprint 还旨在优化患者舒适度，提供70厘米宽的孔径空间、自由呼吸功能以及毯状AIR™线圈以改善患者体验。这一下一代高性能平台设计利用内置的人工智能技术 —— AIR™ Recon DL、Sonic DL™ 和 AIR x™ —— 即使在最具挑战性的解剖结构中也能实现高质量成像。

SIGNA Sprint aims to support clinician goals of providing precision care through the entire care pathway, from the early diagnostic stage to treatment monitoring..

SIGNA Sprint旨在支持临床医生在整个护理过程中提供精准护理的目标，从早期诊断阶段到治疗监测。

Latest in MRI advancements to be showcased at ISMRM

最新的磁共振成像技术进步将在国际磁共振医学学会上展示。

GE HealthCare also will showcase the latest advancements in MRI technologies at ISMRM, including:

GE HealthCare还将在ISMRM上展示MRI技术的最新进展，包括：

SIGNA™ MAGNUS:

SIGNA™ MAGNUS:

A head-only MR scanner designed to support high resolution, high signal-to-noise ratio, diffusion-weighted imaging, and short scan times. GE HealthCare has demonstrated leadership in high-performance gradient technology with the introduction of HyperG gradients, one of the most efficient gradient coils on the market4..

一款仅针对头部的磁共振扫描仪，旨在支持高分辨率、高信噪比、扩散加权成像以及缩短扫描时间。GE HealthCare 通过推出 HyperG 梯度技术展示了其在高性能梯度技术领域的领导地位，这是市场上最高效的梯度线圈之一。

Sonic DL™ 3D:

Sonic DL™ 3D:

Designed to accelerate MRI scans across a wide range of clinical applications, Sonic DL for 3D5 builds on GE HealthCare’s deep learning innovation legacy and the success of AIR Recon DL, which has helped more than 50 million patients to date.

Sonic DL for 3D5 旨在加速各种临床应用中的核磁共振成像扫描，它基于 GE 医疗在深度学习创新方面的传承以及 AIR Recon DL 的成功，后者迄今为止已帮助超过 5000 万名患者。

Freelium™:

自由锂™:

a helium-free sealed6 magnet platform in development, aims to dramatically reduce liquid helium usage without sacrificing power efficiency, operational security and clinical performance.

一个正在开发的无氦气密封磁体平台，旨在大幅减少液氦的使用，同时不牺牲功率效率、操作安全性和临床性能。

Learn more about SIGNA Sprint and other GE HealthCare MRI technologies at the International Society for Magnetic Resonance in Medicine through May 15, in Honolulu, Hawaii, or visit online at gehealthcare.com.

了解有关SIGNA Sprint和其他GE HealthCare MRI技术的更多信息，请于5月15日前在夏威夷檀香山举行的国际医学磁共振学会上参观，或访问gehealthcare.com在线获取更多信息。

About GE HealthCare Technologies Inc.

关于GE医疗科技公司

GE HealthCare is a trusted partner and leading global healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first AI-enabled solutions, services and data analytics. We aim to make hospitals and health systems more efficient, clinicians more effective, therapies more precise, and patients healthier and happier.

GE HealthCare是一家值得信赖的合作伙伴和领先的全球医疗保健解决方案提供商，创新医疗技术、药物诊断以及集成的、以云为先的AI赋能解决方案、服务和数据分析。我们旨在提高医院和卫生系统的效率，提升临床医生的工作效果，使治疗更加精准，并让患者更健康、更快乐。

Serving patients and providers for more than 125 years, GE HealthCare is advancing personalized, connected and compassionate care, while simplifying the patient’s journey across care pathways. Together, our Imaging, Advanced Visualization Solutions, Patient Care Solutions and Pharmaceutical Diagnostics businesses help improve patient care from screening and diagnosis to therapy and monitoring.

服务患者和医疗提供者超过125年的GE HealthCare，正在推进个性化、互联和富有同情心的护理，同时简化患者在治疗路径中的旅程。我们的影像、高级可视化解决方案、患者护理解决方案和药物诊断业务共同协作，帮助改善从筛查、诊断到治疗和监测的整个患者护理过程。

We are a $19.7 billion business with approximately 53,000 colleagues working to create a world where healthcare has no limits..

我们是一家价值 197 亿美元的企业，拥有约 53,000 名同事，致力于创造一个医疗保健没有限制的世界。

GE HealthCare is proud to be among 2025 Fortune World’s Most Admired Companies™.

GE医疗很荣幸被评为2025年《财富》世界最受赞赏公司™之一。

Follow us on LinkedIn, X, Facebook, Instagram, and Insights for the latest news, or visit our website https://www.gehealthcare.com for more information.

请在LinkedIn、X、Facebook、Instagram和Insights上关注我们以获取最新资讯，或访问我们的网站https://www.gehealthcare.com了解更多信息。

SIGNA™ Sprint is 510(k) pending at US FDA. Not yet CE marked. Not available for sale in any region.

SIGNA™ Sprint 在美国 FDA 的 510(k) 审批中，尚未获得 CE 标志，任何地区均未上市销售。

World Health Organization(2025). CVDs statistics and treatment. World Health Organization. Retrieved from https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)

世界卫生组织（2025）。心血管疾病统计与治疗。世界卫生组织。检索自 https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)

World Health Organization. (2025). Cancer statistics and treatment. World Health Organization. Retrieved from https://www.who.int/news-room/fact-sheets/detail/cancer

世界卫生组织（2025）。癌症统计与治疗。世界卫生组织。检索自 https://www.who.int/news-room/fact-sheets/detail/cancer

SIGNA™ MAGNUS is 510(k) cleared with the FDA. Not CE Marked. Not available for sale in all regions. GE HealthCare data on file.

SIGNA™ MAGNUS 已通过 FDA 的 510(k) 认证。未获得 CE 标志。并非在所有地区均可销售。GE HealthCare 数据存档。

Sonic DL for 3D is 510(k) pending at the US FDA. Not yet CE Marked. Not available for sale in all regions.

Sonic DL 用于3D的产品正在美国FDA进行510(k)审批。尚未获得CE标志。并非在所有地区均可销售。

Helium-free: Helium is permanently enclosed in the magnet. Technology in development that represents ongoing research and development efforts. Not for sale. Not CE marked. Not cleared or approved by the US FDA or any other global regulator for commercial availability.

无氦气：氦气被永久封闭在磁体中。此项技术正在开发中，代表了持续的研究与开发努力。未出售。未获得CE标志。未经美国FDA或任何其他全球监管机构批准或认可用于商业用途。